Apollo Endosurgery Inc.

NASDAQ: APEN · Real-Time Price · USD
10.00
0.00 (0.00%)
At close: Apr 03, 2023, 10:00 PM

Company Description

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices.

The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible endoscope.

It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, as well as delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands.

Additionally, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract.

The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Australia, Costa Rica, and other European countries.

Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.

Apollo Endosurgery Inc.
Apollo Endosurgery Inc. logo
Country United States
IPO Date Apr 21, 2005
Industry Medical - Devices
Sector Healthcare
Employees 202
CEO Charles S. McKhann

Contact Details

Address:
Building 1
Austin, Texas
United States
Website https://www.apolloendo.com

Stock Details

Ticker Symbol APEN
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001251769
CUSIP Number 03767D108
ISIN Number US03767D1081
Employer ID 16-1630142
SIC Code 3841

Key Executives

Name Position
Charles S. McKhann Chief Executive Officer, Pres & Director
Jeffrey G. Black Chief Financial Officer, Sec. & Treasurer
Anthony Kalloo M.D. Co-Founder and Innovation Partner
Dr. Christopher J. Gostout M.D. Co-Founder & Chief Medical Officer
Dr. Pankaj Jay Pasricha FACP, M.D., MBBS Co-Founder
Dr. Peter Benjamin Cotton M.D. Co-Founder and Innovation Partner
Dr. Robert Hawes M.D. Co-Founder and Innovation Partner
Dr. Sergey Kantsevoy M.D. Co-Founder and Innovation Partner
John J. Molesphini Executive Vice President of Operations
Sydney Chung M.D. Co-Founder and Innovation Partner

Latest SEC Filings

Date Type Title
May 08, 2023 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Apr 14, 2023 15-12G Filing
Apr 05, 2023 SC 13D/A [Amend] Filing
Apr 04, 2023 4 Filing
Apr 04, 2023 4 Filing
Apr 04, 2023 4 Filing
Apr 04, 2023 4 Filing
Apr 04, 2023 4 Filing
Apr 04, 2023 4 Filing
Apr 04, 2023 4 Filing